PHE have received a number of enquiries about re-calling eligible patients and health care workers who have already received trivalent influenza vaccine (TIV) to additionally give them quadrivalent influenza vaccine (QIV). This is unlikely to be of benefit and recall of such vaccinated individuals is not recommended.
This year the Infection Prevention team held a 22-hour jabathon and have seen a massive increase in uptake for the flu jab in just week one of their campaign. Already more than 2,400 members of staff have had their jab. This just goes to show how keen our staff are to protect our patients.
The October issue features:
flu vaccination – new information leaflet for those aged 65 years of age or older - download or order now!
Plutopox outbreak simulation
New resources - pull up banners for hospitals, social media banners for flu, vaccine packaging poster and a visual guide to vaccines poster
revised inactivated influenza vaccine information for healthcare practitioners
flu vaccine availability and eligibility – 2018 to 2019 children’s programme
adrenaline auto-injector supply issues
ordering restriction on BCG vaccine has been removed
reminder about MMR vaccine ordering restriction
vaccine supply for non routine programmes
We'd like to hear your suggestions for new book alert topics. Simply reply to this email with 'Book Alert Topic' and your suggestions. You can also view and sign-up to our current new book alerts here: http://library.sssft.nhs.uk/librarykeepuptodate
Immunity is the ability of the human body to protect itself from infectious disease. The defence mechanisms of the body are complex and include innate (non-specific, non-adaptive) mechanisms and acquired (specific, adaptive) systems.
The January issue features:
the Falsified Medicines Directive (FMD) as it applies to centrally supplied vaccines for the national immunisation programme
flu vaccine information and availability 2018 to 2019 for the children’s national immunisation programme
BCG vaccine (AJ Vaccines) for the national BCG programme
update on MMR vaccine ordering restriction
fundamentals of immunisation course
Jo Keal and Gail Beckett discuss measles in light of the recent rise in the number of cases in the UK and Europe, leading to outbreaks in vulnerable populations, and explore how practice nurses are in a unique position to influence the health of the wider population. To read the full article, log in using your MPFT NHS OpenAthens details.
Post-exposure treatment (PET) using rabies vaccine with or without human rabies immunoglobulin (HRIG) is highly effective in preventing disease if given correctly and promptly after exposure.
This leaflet is aimed at parents of babies at risk from the hepatitis B virus. It explains the course of vaccinations which help to protect babies from developing an infection.
Several measles outbreaks are ongoing in Europe and until the disease is eradicated worldwide, cross-border transmission between countries is possible and will likely continue to occur.
The President of the Italian National Health Institute, Walter Ricciardi, and the Director of PHE, Duncan Selbie, have stressed that measles elimination in Europe is an objective that needs to be vigorously pursued.
Measles can cause severe complications including encephalitis, pneumonia and even death, and is now a target for elimination in all World Health Organization (WHO) regions.
Adolescent collection (HPV, MenACWY and Td/IPV) user guidance 2017 to 2018
The user guide provides NHS England Local Teams and Screening and Immunisation Teams (SITs) with detailed guidance on how to submit data for the Adolescent Vaccine Coverage Collection (which includes HPV, MenACWY and Td/IPV vaccines) for the 2017 to 2018 Local Authority Annual Survey, via the ImmForm web-based system provided by PHE.